Takahiro Aoki

10PUBLICATIONS
26CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 11, 2026
A Case of a Novel Perforin Gene Variant in Severe Familial Hemophagocytic Lymphohistiocytosis Type 2 (FHL2).

Hiroshi Yamauchi, Moeko Hino, Kazuyuki Meguro

|Nov 26, 2025
Allogeneic iPSC-derived iNKT cells in recurrent head and neck cancer: a phase 1 trial.

Tomohisa Iinuma, Tomoya Kurokawa, Takahiro Aoki

|Nov 13, 2025
Retrospective study of stage IV extracranial germ cell tumors: A report from the Japan Children's Cancer Group.

Yuki Arakawa, Yuya Sato, Shuichiro Uehara

|Aug 18, 2025
Leukoencephalopathy with microbleeds during blinatumomab treatment in a young patient with acute lymphoblastic leukemia.

Yoshiharu Yamashita, Takahiro Aoki, Moeko Hino

|Feb 07, 2025
Antibody-Dependent Cellular Cytotoxicity of iPS Cell-Derived Natural Killer T Cells by Anti-GD2 mAb for Neuroblastoma.

Katsuhiro Nishimura, Takahiro Aoki, Midori Kobayashi

|Feb 06, 2024
Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner.

Mariko Takami, Takahiro Aoki, Katsuhiro Nishimura

Pageof 2